Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

140 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Effect of protein intake on bone mineralization during weight loss: a 6-month trial.
Skov AR, Haulrik N, Toubro S, Mølgaard C, Astrup A. Skov AR, et al. Obes Res. 2002 Jun;10(6):432-8. doi: 10.1038/oby.2002.60. Obes Res. 2002. PMID: 12055318 Clinical Trial.
Topiramate: a new potential pharmacological treatment for obesity.
Astrup A, Toubro S. Astrup A, et al. Obes Res. 2004 Dec;12 Suppl:167S-73S. doi: 10.1038/oby.2004.284. Obes Res. 2004. PMID: 15687413 Review.
A randomized trial of lifestyle modification and taranabant for maintaining weight loss achieved with a low-calorie diet.
Wadden TA, Fujioka K, Toubro S, Gantz I, Erondu NE, Chen M, Suryawanshi S, Carofano W, Johnson-Levonas AO, Shapiro DR, Kaufman KD, Heymsfield SB, Amatruda JM. Wadden TA, et al. Obesity (Silver Spring). 2010 Dec;18(12):2301-10. doi: 10.1038/oby.2010.67. Epub 2010 Apr 8. Obesity (Silver Spring). 2010. PMID: 20379151 Free PMC article. Clinical Trial.
NPY5R antagonism does not augment the weight loss efficacy of orlistat or sibutramine.
Erondu N, Addy C, Lu K, Mallick M, Musser B, Gantz I, Proietto J, Astrup A, Toubro S, Rissannen AM, Tonstad S, Haynes WG, Gottesdiener KM, Kaufman KD, Amatruda JM, Heymsfield SB. Erondu N, et al. Obesity (Silver Spring). 2007 Aug;15(8):2027-42. doi: 10.1038/oby.2007.242. Obesity (Silver Spring). 2007. PMID: 17712121 Clinical Trial.
Weight loss, HbA1c reduction, and tolerability of cetilistat in a randomized, placebo-controlled phase 2 trial in obese diabetics: comparison with orlistat (Xenical).
Kopelman P, Groot Gde H, Rissanen A, Rossner S, Toubro S, Palmer R, Hallam R, Bryson A, Hickling RI. Kopelman P, et al. Obesity (Silver Spring). 2010 Jan;18(1):108-15. doi: 10.1038/oby.2009.155. Epub 2009 May 21. Obesity (Silver Spring). 2010. PMID: 19461584 Clinical Trial.
Conjugated linoleic acids reduce body fat in healthy postmenopausal women.
Raff M, Tholstrup T, Toubro S, Bruun JM, Lund P, Straarup EM, Christensen R, Sandberg MB, Mandrup S. Raff M, et al. J Nutr. 2009 Jul;139(7):1347-52. doi: 10.3945/jn.109.104471. Epub 2009 Jun 3. J Nutr. 2009. PMID: 19494028 Clinical Trial.
Effect of orlistat on weight regain and cardiovascular risk factors following a very-low-energy diet in abdominally obese patients: a 3-year randomized, placebo-controlled study.
Richelsen B, Tonstad S, Rössner S, Toubro S, Niskanen L, Madsbad S, Mustajoki P, Rissanen A. Richelsen B, et al. Diabetes Care. 2007 Jan;30(1):27-32. doi: 10.2337/dc06-0210. Diabetes Care. 2007. PMID: 17192328 Clinical Trial.
Change in beta1-adrenergic receptor protein concentration in adipose tissue correlates with diet-induced weight loss.
Rasmussen M, Belza A, Almdal T, Toubro S, Bratholm P, Astrup A, Christensen NJ. Rasmussen M, et al. Clin Sci (Lond). 2005 Apr;108(4):323-9. doi: 10.1042/CS20040238. Clin Sci (Lond). 2005. PMID: 15574119
Subjects lost 12.8+/-0.8 kg (mean+/-S.E.M.) during diet treatment. There was a 34% decrease in the beta(1)-adrenergic receptor mRNA level (0.92+/-0.09 compared with 0.61+/-0.06 amol/microg of DNA; P<0.002). ...
Subjects lost 12.8+/-0.8 kg (mean+/-S.E.M.) during diet treatment. There was a 34% decrease in the beta(1)-adrenergic receptor mRNA l …
Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-alpha. Effect of weight loss in obese men.
Bruun JM, Verdich C, Toubro S, Astrup A, Richelsen B. Bruun JM, et al. Eur J Endocrinol. 2003 May;148(5):535-42. doi: 10.1530/eje.0.1480535. Eur J Endocrinol. 2003. PMID: 12720537
140 results
Jump to page